Related Experiment Videos
Implementation of Current Good Manufacturing Practices in a small research laboratory setting
1Research Triangle Institute, Research Triangle Park, North Carolina 27709, USA.
Quality Assurance (San Diego, Calif.)
|March 1, 1995
Summary
Applying Current Good Manufacturing Practice (cGMP) regulations in research labs requires careful planning and understanding. This article details strategies for successfully implementing drug manufacturing standards in a research setting.
Area of Science:
- Pharmaceutical Sciences
- Regulatory Affairs
- Laboratory Management
Background:
- Current Good Manufacturing Practice (cGMP) regulations (21 CFR 211) primarily govern industrial drug manufacturing.
- Adapting these regulations to research laboratory settings presents unique challenges.
- Successful implementation necessitates a deep understanding of regulatory intent.
Purpose of the Study:
- To describe the practical application of cGMP regulations within a research laboratory.
- To provide insights into overcoming challenges when implementing cGMP in non-traditional manufacturing environments.
- To share experiences and strategies for regulatory compliance in research settings.
Main Methods:
- Analysis of the fundamental principles of cGMP (21 CFR 211).
- Identification of key requirements for adapting industrial regulations to research operations.
- Development of a framework for management commitment and inter-departmental cooperation (QA/QC and technical staff).
Main Results:
- cGMP can be effectively applied in research laboratories with appropriate management support and staff collaboration.
- A creative and flexible approach, focusing on the spirit of the law, is crucial for successful implementation.
- Breaking down regulations into core components aids understanding and application in research contexts.
Conclusions:
- Implementing cGMP in research labs is feasible and beneficial for ensuring product quality and regulatory adherence.
- Success hinges on a combination of management dedication, cross-functional teamwork, and a nuanced understanding of regulatory intent.
- This approach facilitates the transition of research findings into potential pharmaceutical products while maintaining high standards.